-
1
-
-
84873412121
-
Familial urticaria pigmentosa: Report of a family and review of the role of KIT mutations
-
Fett NM, Teng J, Longley BJ,. Familial urticaria pigmentosa: report of a family and review of the role of KIT mutations. Am J Dermatopathol 2013; 35: 113-116.
-
(2013)
Am J Dermatopathol
, vol.35
, pp. 113-116
-
-
Fett, N.M.1
Teng, J.2
Longley, B.J.3
-
2
-
-
32844455834
-
A novel K509I mutation of KIT identified in familial mastocytosis - In vitro and in vivo responsiveness to imatinib therapy
-
Zhang LY, Smith ML, Schultheis B, et al. A novel K509I mutation of KIT identified in familial mastocytosis-in vitro and in vivo responsiveness to imatinib therapy. Leuk Res 2006; 30: 373-378.
-
(2006)
Leuk Res
, vol.30
, pp. 373-378
-
-
Zhang, L.Y.1
Smith, M.L.2
Schultheis, B.3
-
4
-
-
84873742712
-
A c-kit mutation in exon 18 in familial mastocytosis
-
Wohrl S, Moritz KB, Bracher A, et al. A c-kit mutation in exon 18 in familial mastocytosis. J Invest Dermatol 2013; 133: 839-841.
-
(2013)
J Invest Dermatol
, vol.133
, pp. 839-841
-
-
Wohrl, S.1
Moritz, K.B.2
Bracher, A.3
-
5
-
-
19444371824
-
A germline mutation in KIT in familial diffuse cutaneous mastocytosis
-
Tang X, Boxer M, Drummond A, et al. A germline mutation in KIT in familial diffuse cutaneous mastocytosis. J Med Genet 2004; 41: e88.
-
(2004)
J Med Genet
, vol.41
, pp. e88
-
-
Tang, X.1
Boxer, M.2
Drummond, A.3
-
6
-
-
79960629726
-
Novel, activating KIT-N822I mutation in familial cutaneous mastocytosis
-
Wasag B, Niedoszytko M, Piskorz A, et al. Novel, activating KIT-N822I mutation in familial cutaneous mastocytosis. Exp Hematol 2011; 39: 859-865.
-
(2011)
Exp Hematol
, vol.39
, pp. 859-865
-
-
Wasag, B.1
Niedoszytko, M.2
Piskorz, A.3
-
7
-
-
0035425217
-
Germline mutation in the juxtamembrane domain of the kit gene in a family with gastrointestinal stromal tumors and urticaria pigmentosa
-
Beghini A, Tibiletti MG, Roversi G, et al. Germline mutation in the juxtamembrane domain of the kit gene in a family with gastrointestinal stromal tumors and urticaria pigmentosa. Cancer 2001; 92: 657-662.
-
(2001)
Cancer
, vol.92
, pp. 657-662
-
-
Beghini, A.1
Tibiletti, M.G.2
Roversi, G.3
-
8
-
-
24144503371
-
Novel germline mutation of KIT associated with familial gastrointestinal stromal tumors and mastocytosis
-
Hartmann K, Wardelmann E, Ma Y, et al. Novel germline mutation of KIT associated with familial gastrointestinal stromal tumors and mastocytosis. Gastroenterology 2005; 129: 1042-1046.
-
(2005)
Gastroenterology
, vol.129
, pp. 1042-1046
-
-
Hartmann, K.1
Wardelmann, E.2
Ma, Y.3
-
9
-
-
76649094569
-
Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations
-
Bodemer C, Hermine O, Palmerini F, et al. Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations. J Invest Dermatol 2010; 130: 804-815.
-
(2010)
J Invest Dermatol
, vol.130
, pp. 804-815
-
-
Bodemer, C.1
Hermine, O.2
Palmerini, F.3
-
10
-
-
54349098330
-
Association of paediatric mastocytosis with a polymorphism resulting in an amino acid substitution (M541L) in the transmembrane domain of c-KIT
-
Foster R, Byrnes E, Meldrum C, et al. Association of paediatric mastocytosis with a polymorphism resulting in an amino acid substitution (M541L) in the transmembrane domain of c-KIT. Br J Dermatol 2008; 159: 1160-1169.
-
(2008)
Br J Dermatol
, vol.159
, pp. 1160-1169
-
-
Foster, R.1
Byrnes, E.2
Meldrum, C.3
-
11
-
-
84878784109
-
Genome sequencing of mucosal melanomas reveals that they are driven by distinct mechanisms from cutaneous melanoma
-
Furney SJ, Turajlic S, Stamp G, et al. Genome sequencing of mucosal melanomas reveals that they are driven by distinct mechanisms from cutaneous melanoma. J Pathol 2013; 230: 261-269.
-
(2013)
J Pathol
, vol.230
, pp. 261-269
-
-
Furney, S.J.1
Turajlic, S.2
Stamp, G.3
-
12
-
-
22144455380
-
Activation mutations of human c-KIT resistant to imatinib mesylate are sensitive to the tyrosine kinase inhibitor PKC412
-
Growney JD, Clark JJ, Adelsperger J, et al. Activation mutations of human c-KIT resistant to imatinib mesylate are sensitive to the tyrosine kinase inhibitor PKC412. Blood 2005; 106: 721-724.
-
(2005)
Blood
, vol.106
, pp. 721-724
-
-
Growney, J.D.1
Clark, J.J.2
Adelsperger, J.3
-
13
-
-
84872345873
-
KIT D816 mutation associates with adverse outcomes in core binding factor acute myeloid leukemia, especially in the subgroup with RUNX1/RUNX1T1 rearrangement
-
Kim HJ, Ahn HK, Jung CW, et al. KIT D816 mutation associates with adverse outcomes in core binding factor acute myeloid leukemia, especially in the subgroup with RUNX1/RUNX1T1 rearrangement. Ann Hematol 2013; 92: 163-171.
-
(2013)
Ann Hematol
, vol.92
, pp. 163-171
-
-
Kim, H.J.1
Ahn, H.K.2
Jung, C.W.3
-
14
-
-
0033820064
-
Mutations in exons 9 and 13 of KIT gene are rare events in gastrointestinal stromal tumors. A study of 200 cases
-
Lasota J, Wozniak A, Sarlomo-Rikala M, et al. Mutations in exons 9 and 13 of KIT gene are rare events in gastrointestinal stromal tumors. A study of 200 cases. Am J Pathol 2000; 157: 1091-1095.
-
(2000)
Am J Pathol
, vol.157
, pp. 1091-1095
-
-
Lasota, J.1
Wozniak, A.2
Sarlomo-Rikala, M.3
-
15
-
-
44849118922
-
Phenotypic and genotypic characteristics of mastocytosis according to age of onset
-
Lanternier F, Cohen-Akenin A, Palmerini F, et al. Phenotypic and genotypic characteristics of mastocytosis according to age of onset. PLoS One 2008; 3: e1906.
-
(2008)
PLoS One
, vol.3
, pp. e1906
-
-
Lanternier, F.1
Cohen-Akenin, A.2
Palmerini, F.3
|